default search action

combined dblp search
author search
venue search
publication search

ask others

Gundián M. de Hijas-Liste

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2010 – 2019

see FAQ

What is the meaning of the colors in the publication lists?

2015
[j2]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/Hijas-ListeBEBL15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/Hijas-ListeBEBL15
Gundián M. de Hijas-Liste, Eva Balsa-Canto, Jan Ewald, Martin Bartl, Pu Li, Julio R. Banga, Christoph Kaleta:
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation. BMC Bioinform. 16: 163:1-163:13 (2015)
2014
[j1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcsb/Hijas-ListeKBB14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcsb/Hijas-ListeKBB14
Gundián M. de Hijas-Liste, Edda Klipp, Eva Balsa-Canto, Julio R. Banga:
Global dynamic optimization approach to predict activation in metabolic pathways. BMC Syst. Biol. 8: 1 (2014)
2013
[c1]
- view
  authority control:
- export record
  dblp key:
  - conf/med/Hijas-ListeBBK13
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/med/Hijas-ListeBBK13
Gundián M. de Hijas-Liste, Eva Balsa-Canto, Julio R. Banga, Christoph Kaleta:
Optimal regulatory programs for the control of metabolic pathways: The case of feedback inhibition. MED 2013: 237-242

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.